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Summary 
The immunoglobulin E (IgE) response is generally considered an essential component of the 
host  defense against  parasitic  helminths  such  as  Schistosoma  mansoni.  In contrast,  work on 
antischistosome vaccines suggests that interferon 3' (IFN-3,) is the critical immune mediator for 
vaccine-induced immunity to the parasite.  In this study, the total IgE response to a primary 
S. mansoni infection was suppressed by anti-IgE treatment in both normal mice and in mice with 
defective IFN genes (gene knockout [GKO]). Reduction of the IgE response resulted in decreased 
worm burden and a decrease in the number of eggs produced per worm in both normal and 
GKO mice. Whereas anti-IgE treatment also resulted in reduced hepatosplenomegaly, granulomas 
around existing schistosome eggs showed normal cellularity. Serum interleukin 4 levels fell in 
response to the reduction in serum IgE as well. The data suggest that IgE plays a detrimental, 
rather than beneficial, role for the host in schistosomiasis.  Furthermore, the absence of IFN-3, 
was found to be of little consequence to the host-response to adults or eggs in a primary schistosome 
infection. 
n elevated IgE antibody response is a hallmark of infec- 
tion with parasitic helminths, including Schistosoma man- 
soni,  which infect an estimated 250  million people world- 
wide (1-3). It is a widely accepted hypothesis that this IgE 
response evolved as a host defense against metazoan parasites 
(4, 5).  Certainly, numerous studies support the hypothesis 
that  IgE is  important  in acquired resistance to  secondary 
schistosome infection: B cell depletion prevents development 
of immunity (6), effective immunity can be adoptively trans- 
ferred by IgE antibodies (7, 8), and in vitro IgE can directly 
mediate  resistance  through  eosinophil,  macrophage,  and 
platelet-mediated cytotoxicity (4, 9, 10). In addition, recent 
epidemiological reports suggest a correlation between high 
schistosome-specific IgE antibody levels and resistance to rein- 
fection (11-13). On the other hand, studies of vaccine-induced 
immunity suggest that IFN-% rather than IgE, is the im- 
portant effector molecule for acquired immunity (14, 15). 
Indeed,  treatment with  an anti-IFN-v  antibody has been 
shown to reduce immunity to schistosomiasis (16).  IFN-3, 
has also been implicated in schistosome egg-induced granu- 
loma formation (17). 
In this study, we evaluated the contributions of IgE and 
IFN-y in the host defense against a primary infection with 
S. mansoni. The relative roles of IgE and IFN-3, were exam- 
ined in  a  murine model of schistosomiasis in  which IgE 
was eliminated using a monoclonal anti-IgE antibody, and 
IFN-3, was eliminated via gene knockout (GKO) 1 (18). We 
report that anti-IgE mAb treatment of both wild type and 
GKO mice completely blocked production of IgE, yet re- 
duced the number of adult worms and dramatically reduced 
egg production leading to amelioration of hepatosplenomegaly. 
These findings suggest that in primary infections, the IgE 
response stimulated by S. mansoni infection is an immunopatho- 
logical consequence of the host-parasite interaction rather 
than a protective immune response. 
Materials and Methods 
Collection of S.  mansoni Cercariae.  The life cycle S.  mansoni is 
maintained in the laboratory of Dr. McKerrow at the Veteran's 
P. Amiri and M. Haak-Frendscho  contributed equally to this work.  1 Abbreviation used in this paper: GKO, gene knockout. 
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host, and Biomphalaria glabrata snails as the intermediate host. Cer- 
cariae of S. mansoni were collected by placing infected snails in a 
darkroom for 3-4 d. Shedding of cercariae into spring water (with 
100/~g/ml  gentamycin) was induced by placing snails under an 
incandescent light for 2 h. 
Infection of Mice with S.  mansoni Cercariae.  BALB/c and (129 
/SvXC57BL/6)F2 (wild-type) mice were purchased from Charles 
River Laboratories (Portage, MI).  IFN-y (GKO) mice were ob- 
tained from a breeding colony at Genentech. All the mice were 
housed under microisolator caps in a quarantine room. Once accli- 
mated to our facility,  the 5-7-wk-old mice were treated intrave- 
nously with either 100 #g anti-lgE mAb (K35-92, rat IgG1; Phar- 
mingen, San Diego, CA) or an isotype-matched control antibody 
(rat IgGl,r; PharMingen). The next day, all the mice were injected 
subcutaneously with 90  _-4- 5 cercariae  of S.  mansoni. At weekly 
intervals,  mice were bled and then retreated intravenously with 20 
#g anti-lgE mAb or isotype-matched control antibody at weeks 
1, 2, 3, 4, and 5 and with 100 #g at weeks 6 and 7 (total of 400 
#g), or with 20 #g anti-IgE mAb weekly (total of 240 #g). GKO 
mice (5-9 per group) were treated with a total of 400 #g of the 
anti-lgE mAb or the isotype control. Total serum IgE was deter- 
mined by ELISA.  There was no effect of the rat anti-IgE Ab on 
the ability to detect IgE using this assay format. 
Quantitation of  Aduh Worms.  Mice were killed by interperitoneal 
injection of 15 mg of pentobarbital (Fort Dodge Laboratories, Inc., 
Fort Dodge, IA) and 60 U of heparin (Elkins-Simm Inc., Cherry 
Hill, NJ). After 10 min, adult worms were recovered by perfusion 
of the portal venous system (19). Numbers reported are the mean 
number of worms per mouse (n  =  7-12 per group)  _+  standard 
deviation. 
Quantitation of  S. mansoni Eggs in the Liver.  Livers were removed 
from the mice after the perfusion (above) and placed in Earl's Basic 
Salt Solution (GIBCO BRL Life Technologies,  Inc., Gaithersburg, 
MD) containing 1% type III trypsin (Sigma  Chemical Co.,  St. 
Louis, MO) and 0.1% collagenase A (Boehringer Mannheim Bio- 
chemicals, Indianapolis, IN). The liver was homogenized for 20-30 s 
using a Polytron homogenizer (Brinkmann Instruments, Westbury, 
NY). The mixture was allowed to incubate at 37~  for 12 h. At 
the end of the incubation period, the mixture was  shaken  well, 
20-/~1 samples were removed, and the total number of eggs in the 
sample  was counted under a microscope at a magnification of 5. 
The results are reported as the mean total egg number of 10 in- 
dependently counted samples  per liver  _+  standard deviation. 
Evaluation of Histopathology.  Liver and spleen were removed and 
weighed after perfusion of portal venous system and tissue samples 
(portion of liver and spleen) were fixed for 12 h in 10% phosphate- 
buffered formalin followed by embedding in paraffin blocks. Paraffin 
sections were cut at 5 #m and stained with hematoxylin and eosin. 
Antibodies.  Rabbit polyclonal anti-mouse IgE, hamster anti- 
recombinant murine (mlFN-y), rabbit anti-recombinant mlFN-"/, 
recombinant mlFN-%  and biotinylated IgE receptor I-lgG im- 
munoadhesin (20) were manufactured at Genentech. Mouse IgE, 
rat anti-mouse Ib4 mAb, biotin-conjugated rat anti-mouse Ib4, 
and FITC-conjugated rat anti-mouse CD23 were purchased from 
PharMingen.  Mouse  IL-4 was  from  R&D  Systems,  Inc.  (Min- 
neapolis, MN). Horseradish peroxidase-conjugated  donkey anti-rab- 
bit Ig was obtained from Amersham Corp. (Arlington Heights, 
IL). mAb recognizing CD45R-R.ed613  was from GIBCO BRL. 
Horseradish peroxidase-conjugated  streptavidin was purchased from 
Zymed Laboratories (S. San Francisco,  CA). 
FACS  ~ Analysis.  Spleens were removed from anti-lgE mAb 
and control antibody treated mice after 8 wk of infection with 
S. mansoni. Cells were dispersed with frosted glass slides and washed 
with PBS containing 1% BSA and 0.1%  sodium azide (staining 
buffer). 1@ cells were stained with appropriate dilutions of mAbs 
recognizing CD45K (RA3-6B2, Red613) and CD23(B3B4, FITC 
conjugated) for 30 min at 4~  Splenocytes from uninfected mice 
were used for reference B cell expression of CD23. Cells were washed 
and fluorescence intensity was measured on a FACScan  |  flow cytom- 
eter (Becton Dickinson & Co., Mountain View, CA). Cells were 
gated to eliminate dead cells and debris by using forward and side 
light scatter. 
Con A Stimulation of Splenocytes.  Spleen cells were dispersed with 
frosted glass slides and 106 cells/ml were cultured in DMEM con- 
taining 10% FBS, 5  x  10-s M 2-ME,  100 U/ml penicillin,  and 
100 mg/ml streptomycin (GIBCO BILL) at 37~  5%  CO2.  5 
#g/ml Con A was added at initiation of the culture, and superna- 
tants for ELISA were harvested after 72 h. 
ELISA.  Microtiter plates (Immuno MaxiSorp; Nunc, Koskilde, 
Denmark)  were coated overnight at  4~  with  either 2 #g/ml 
polyclonal rabbit anti-mouse IgE,  1 #g/ml rat anti-mouse I1;4 
mAb (BVD4-1D11, IgG2b), or I #g/ml hamster anti-recombinant 
mlFN-% depending on the assay format, in 0.05 M sodium car- 
bonate/bicarbonate, pH 9.6. Plates were washed with PBS/0.1% 
Tween 20 and unbound protein sites were blocked for I h at room 
temperature  with  100  #1  of 50  mM  TBS/0.5%  BSA/2  mM 
EDTA/0.05% Tween 20 (ELISA buffer). After washing three times, 
twofold dilutions of serum from treated mice or supernatants from 
cultured splenocytes  were added for 2 h  and then washed. 
To detect total serum IgE, biotinylated lgE receptor I-IgG im- 
munoadhesin (1:1,000 in ELISA buffer) was added and plates were 
incubated for 90 min at room temperature. The plates were washed 
and incubated for 1 h with horseradish  peroxidase conjugated to 
streptavidin (1:4,000  in ELISA buffer) followed by washing and 
the addition of the developing substrate o-phenylenediamine di- 
hydrochloride (OPD, Sigma Chemical Co.). 
II.-4 concentrations were determined using biotin-conjugated 
anti-mouse 11.-4 (BVD6-24G2, rat IgG1; 1 #g/ml in ELISA buffer). 
After washing, the plates were incubated for 1 h with horseradish 
peroxidase conjugated to streptavidin (1:4,000 in ELISA buffer) fol- 
lowed by OPD. 
IFN-3~ in supernatants from Con A-stimulated splenocytes was 
detected with rabbit anti-recombinant mlFN-y followed by a 90- 
min incubation with horseradish  peroxidase-conjugated donkey 
anti-rabbit lg (1:5,000 in ELISA buffer) before the developing sub- 
strate OPD  was  added. 
Results 
We began with an examination of the role of IgE in pri- 
mary schistosome infection. In the first series of experiments, 
normal BALB/c mice were infected with S. mansoni cercariae 
and treated weekly with a total of 400/~g of anti-IgE mAb 
(high dose). This treatment reduced serum IgE to undetect- 
able levels (<3 ng/ml) during the 8-wk course of the infec- 
tion (Fig.  1). The assay used for quantitation of IgE detects 
both  free IgE and  IgE complexed to the antibody and,  as 
such, measures the total serum IgE concentration. A second 
group of mice treated with  a lower dose of anti-IgE mAb 
weekly (240 #g/total)  had measurable  IgE responses (<50 
#g/ml) during the last 2 wk of the infection. The IgE levels 
in the antibody treated mice were markedly reduced com- 
pared with infected mice treated with the isotype control an- 
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Figure  1.  Effect  of anti-IgE mAb or control  antibody 
treatment on total serum IgE levels  in BALB/c mice. All 
the mice were treated with 100 #g of anti-IgE mAb or 
the isotype-matched  control IgG antibody I d before  ex- 
posure to parasites. At weekly  intervals, mice were bled 
and then retreated intravenously  with a total of 400 or 
240 #g of anti-IgE mAb or IgG. Total serum IgE was 
determined  by ELISA  using  polyclonal  rabbit anti-mouse 
IgE. 
tibody which exhibited typically high serum IgE levels (240 
/zg/ml) by the eighth week of infection. 
In agreement with previous reports, a significant but in- 
complete reduction in serum IgE levels had little effect on 
either parasite burden or the number of eggs produced per 
worm (Table 1). In contrast, infected mice, which had unde- 
tectable IgE levels as a result of treatment with the higher 
dose of anti-IgE mAb,  had a significant reduction in the 
number of adult worms and the number of eggs produced, 
as compared with the control group. 
The reduction in egg production resulting from antibody 
treatment had a measurable effect on the cellular response 
to infection. Granuloma formation around schistosome eggs 
trapped in the portal venules of the liver is the key patholog- 
ical event in schistosomiasis (21, 22).  Histopathological ex- 
amination of the infected animals revealed that organ size cor- 
related with the tissue inflammatory response (Fig. 2 A). In 
the high dose mAb-treated mice, hepatosplenomegaly was 
diminished by ~o50%  when compared with control IgG 
treated mice. This was due to the decrease in egg production 
which in turn resulted in marked reductions in the number 
of granulomas in the livers of the high dose anti-IgE mab 
treated mice (Fig.  2 B). 
The cellular composition of the granulomas was not ap- 
preciably altered. Well developed granulomas with numerous 
macrophages and eosinophils were observed in all groups of 
mice. However, the high dose treatment group did show de- 
creased granuloma-associated fibrosis (Fig. 2, C and D). Ad- 
ditional immunohistochemical staining of the inflammatory 
infiltrate for reticulin fibers (data not shown) revealed little 
fibrosis around the eggs in the anti-IgE treated mice, whereas 
a distinct fibrotic reaction was evident around the eggs in 
the IgG controls. 
In addition to eliciting a potent inflammatory response, 
schistosome eggs are a powerful stimulus for donal expan- 
sion and activation of the Th2 subclass of CD4 + T cells (23, 
24) which release specific cytokines, including IL-4 (25). In 
these experiments, serum IL-4 rose to detectable levels during 
the seventh  and eighth weeks of infection in control anti- 
body treated mice (Fig.  3).  This rise coincided with egg 
production (26). However, there was no similar spike of IL-4 
in the sera of infected mice treated with anti-IgE mAb (Fig. 4). 
The  decrease  in  IL-4 levels after anti-IgE treatment of 
schistosome-infected  mice was reflected in differential surface 
marker expression  of splenic B cells in the treated mice ex- 
amined at 8 wk after infection with cercariae. Examination 
of FceRII (CD23), the low affinity  receptor for IgE, on splenic 
B cells revealed that the receptor level was elevated in response 
Table  1.  Effect of Anti-IgE on Egg-laying by S.  mansoni Worms In  Vivo 
Control Ab  Anti-IgE  Anti-IgE 
Treatment  (400/zg)  (400/zg)  (400/~g)  (240/zg) 
Number  of adult worms 
Total no. of eggs/liver 
Mean no. eggs/adult 
41  _+  10  20  +  2*  42  +  10 
27,061  +  1,128  5,557  +  1,595"  23,369  +  4,927 
656  _+  162  268  _+  72*  556  +- 69 
* Significant at P <0.05 as determined  by analysis of variance; comparisons were performed using the Student-Newman-Keul  Test. 
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Figure  3.  Effect of anti-IgE mAb or control antibody treat- 
ment on serum  Ib4 levels of schistosome-infected  BALB/c 
mice.  Serum  11.-4 level was  determined  by  ELISA  using 
anti-mouse Ib4 mAb. 
to schistosome infection in the control mice. This increased 
expression was not  seen in mice treated with  the anti-IgE 
mAb (Fig.  4). Since IL-4 is known to increase cell surface 
expression of CD23  (27),  the lack of enhanced  CD23  ex- 
pression is consistent with the absence of detectable IL-4 levels 
in  the anti-IgE  treated  mice. 
To  investigate  the  relative  contribution  of Thl-derived 
cytokines in this system, sera were assayed for IFN-y which 
has been shown to confer vaccine-induced protective immu- 
nity to S. mansoni (28). Although the ELISA used was sensi- 
tive to 15 pg/ml,  no circulating IFN-'y was detected in any 
of the serum  samples collected during  the 8-wk course of 
primary schistosome infection (data not shown).  However, 
IFN-3, levels  were measurable in  the  supernatants  of Con 
A-stimulated spleen cells taken from either uninfected mice 
or from infected mice treated with anti-IgE or control anti- 
body. In agreement with published findings (29), IFN-qr levels 
in the cultures were greatly suppressed 8 wk after infection 
(560 pg/ml uninfected mice vs. 18 pg/ml infected mice).  It 
is interesting to note that treatment with the anti-IgE anti- 
body partially reversed this suppression elevating IFN-3' to 
67 pg/ml in the supernatants  of splenocytes from infected mice. 
To investigate the role of IFN-3' in the immune response 
to primary S. mansoni infection in the anti-IgE treated mice, 
GKO mice were infected with the parasite and treated with 
the anti-IgE or control antibody (Fig. 5). It is surprising that 
GKO and wild-type mice treated with the control antibody 
were found to have equivalent responses to the parasites (Fig. 
6). Almost identical numbers of worms and eggs were re- 
covered from each group. Furthermore,  there were no differ- 
ences in the number or appearance of granulomas in the two 
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Figure  4.  CD23 cell surface expw~sion on splenoeytes. Splenocytes from 
uninfected  mice were used for reference for B cell expression of CD23 
(A). Cells from mice treated with control antibody (B) showed a marked 
upregulation  of CD23 expression in response to schistosome  infection. 
In contrast,  CD23 expression on spleen cells was reduced as a result  of 
anti-IgE mAb treatment (C). 
groups. However, similar to the results seen in the BALB/c 
mice,  treatment  of the GKO mice with the anti-IgE  anti- 
body did result in a decrease in worm burden and egg produc- 
tion.  Thus,  the effect of anti-IgE  treatment  would appear 
to be independent  of IFN-3,. 
The  lack  of IFN-3,  production  in  the  GKO  mice  was 
confirmed by the absence of IFN-3' after Con A stimulation 
of splenocytes (Fig. 7 A). Given the well-established  suppressive 
effects of IFN-3, on IgE synthesis,  it is noteworthy that serum 
IgE levels in the GKO mice were not elevated compared with 
wild-type mice. This may reflect lower IL-4 levels in these 
mice since in this experiment,  splenocytes from the GKO 
Figure  2.  Cellular reaction to schistosome eggs trapped in the liver of schistosome-infected  BALB/c mice. Liven from control antibody treated mice 
contained  multiple large coalescing loci of granulomas  predominately  composed  of macrophages  and eosinophils (A).  Livers of anti-lgE mAb treated 
animals had fewer eggs and therefore  fewer granulomas  (B). The histologic characteristics,  notably  the presence of macrophages  and numerous  eo- 
sinophils,  were similar in both groups.  However, the granulomas  of the anti-lgE treated  group (D) did appear to have less fibrosis than those from 
control mice (C). 
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Figure  5.  Serum  IgE levels of schistosome  infected 
GKO or wild-type mice (five to nine per group) treated 
with a total of 400/~g of the anti-IgE mAb or the control 
(IgG)  antibody. 
mice produced decreased levels of IL-4 in response to Con 
A  stimulation (Fig. 7 B). 
Discussion 
It has been difficult to determine the precise role of IgE 
in models of parasite infection since most of the studies have 
employed systems  in which IgE is deficient as a result of genetic 
mutation(s) or via elimination of the pluripotent lymphokine 
IL-4 which acts as a switch factor for IgE and IgG1 and is 
required for IgE synthesis (30). Treatment of mice with anti- 
IL-4 antibodies reduced serum IgE along with IL-4, but failed 
to alter immunity against S.  mansoni (15). Since both IL-4 
and IgE levels were affected in this  study, it is difficult to 
separate the effects of removal of IgE alone from the pluripo- 
tent effects of IL-4 removal. Likewise, attempts to suppress 
only IgE levels using a polyclonal anti-IgE antiserum showed 
no detrimental effect on curing a primary infection orS. man- 
soni  in rats (31). However,  since that study measured only 
worm-specific IgE responses, it is unclear to what degree the 
nonspecific IgE response or the IgE response to the other 
forms of the parasite was suppressed by the dose of anti-IgE 
antibody used. It has been shown that schistosome-specific 
IgE constitutes  <10% of the total IgE made in response to 
the infection (32). The suggestion  has been made that the 
presence of this disproportionately  high level of total non- 
parasite IgE may be protective for the parasite since these IgE 
molecules would saturate the available FceRs and prevent para- 
site antigen-specific mediator release (33). Here we measured 
the total IgE response to assure that the nonspecific IgE levels 
were completely suppressed throughout the entire course of 
the infection.  Measurement of antigen-specific IgE  titers 
confirmed this result (data not shown). Clearly, suppression 
of the total IgE response to undetectable levels, rather than 
a partial reduction in IgE levels, was beneficial for the host 
as measured by decreases in worm burden and egg produc- 
tion. This reduction in egg production does not appear to 
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be due to a shift in kinetics, since in other reinfection experi- 
ments, identical results were seen as late as 15 wk after infec- 
tion (our unpublished results). 
The reduction in egg production in the anti-IgE treated 
mice is striking.  Since it has been shown that TNF-ot is re- 
quired for egg laying by schistosomes (34) the reduction in 
IgE levels after antibody treatment may have resulted in a 
reduction in the IgE-dependent release of TNF-ot by perito- 
neal mast cells (35, 36). The lack of IgE to trigger mast cell 
degranulation would lead to lower TNF-o~ levels and could 
account for the decreased  egg production in the anti-IgE treated 
mice. This condusion is supported by the results seen in the 
low dose anti-IgE treated mice. In this experiment, when 
IgE was detectable during the last 2 wk of the infection, egg 
production and the resultant hepatosplenomegaly  were equiva- 
lent to the control antibody treated animals. 
The decrease in egg production would be expected to have 
an impact on the cellular response to this parasite since schisto- 
some eggs are known to be potent inducers of Th2 cells. Thus, 
the decreased egg numbers may have resulted in decreased 
Th2 stimulation thereby decreasing IL-4 production since Th2 
cells are a primary source of this cytokine.  This could ac- 
count for the decreased IL-4 levels observed in the anti-IgE 
treated mice. Alternatively, as suggested for TNF-c~, decreased 
IgE levels after antibody treatment could lead to decreased 
mast cell degranulation and release of IL-4 from the granules 
since it has been shown that mast cells are an important source 
of IL-4 which is released after receptor cross-linking  (37). 
Indeed, FceR-positive  cells are a major source of  IL-4 in spleens 
of  mice infected with S. mansoni (38). These findings suggest 
that in addition to IL-4 directing IgE synthesis, IgE feeds 
back to amplify IL-4 release, thus modulating its own pro- 
duction. 
Decreased IL-4 levels could also account for the observed 
decrease in CD23 expression since IL-4 is known to be in- 
volved in upregulation of CD23 expression. CD23 can act 
quite efficiently in the capture and preferential presentation 
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of antigens to Th2 cells (39) leading to induction of IgE re- 
sponses. Thus, a reduction in CD23 expression would lead 
to a further decrease in Th2 stimulation. 
Previous reports have established an association with Thl 
stimulation and protection against adult worms versus Th2 
stimulation and egg-induced immunopathology (40). It has 
also been suggested that the Th2 response to schistosome 
eggs results in downregulation of the Thl response (37). The 
improved response to the parasite after elimination of IgE 
via anti-IgE treatment may result from shifting the balance 
from a Th2 towards a Thl response, resulting in the pro- 
duction of cytokines that are reported to be more effective 
in controlling the parasite infection (17). The increase  in IFN-y 
levels observed after anti-IgE treatment suggested this shift 
toward a Thl response was occurring. 
We tested the role of IFN-  3, directly by treating schistosome- 
infected mice, defective in the IFN-3'  gene, with the anti- 
IgE antibody. Since there was little difference in the ability 
of wild-type or GKO mice to respond to infection, the data 
suggest that IFN-y does not play a central role in the devel- 
opment  of immunity to  primary  schistosome  infection. 
Nevertheless, elimination of IFN-3' with an anti-IFN-3, an- 
tibody has been shown to reduce vaccine-induced immunity 
to schistosomiasis (15). 
Treatment of the GKO mice with the anti-IgE antibody 
did result in a decrease in worm burden and egg production. 
Thus it would appear that the protective effect of the anti- 
IgE treatment is independent of IFN-3, production. IFN-3, 
is well accepted as a downregulator of IgE synthesis (41). 
If IgE plays a negative role in immunity to schistosomiasis, 
then one may speculate that the reduction in immunity as 
a consequence of decreased IFN-y levels resulted from an in- 
crease in IgE production. Indeed,  in other experiments  in 
mice unable to produce IFN-y because of disruptions of their 
IFN genes, we observed enhanced IgE production in response 
to bacillus Calmette Gu&in infection (our unpublished ob- 
servations). Our results demonstrate that suppression of IgE synthesis 
lowers worm burden,  egg production,  and hepatospleno- 
megaly in routine schistosomiasis and support the notion that 
the IgE response stimulated by S.  mansoni may be parasite 
rather than host protective, at least in primary infections (33). 
We are currently investigating the role of IgE and cytokines 
like IFN-3' in resistance to secondary infection and vaccine- 
induced immunity. 
Address correspondence to P. Jardieu, Department of Immunology, Genentech, Inc., 460 Point San Bruno 
Boulevard, South San Francisco, CA 94080-6000. 
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